DLG4-related synaptopathy
Zuletzt aktualisiert 3 Nov 2023
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
DLG4-related synaptopathy is a condition that affects neurological development. This condition is characterised by delayed development and mild to moderate intellectual disabilities that typically becomes evident before age 2. Over time, many individuals with DLG4-related synaptopathy lose skills that they have learned, such as speech or motor skills. About 20 percent of people with this condition cannot speak. Affected individuals often have neurodevelopmental disorders, such as autism spectrum disorder or attention-deficit/hyperactivity disorder. About half of individuals with this condition have recurrent seizures (epilepsy) that typically begin in childhood. Brain changes can also occur. These include brain tissue loss (atrophy) and abnormalities of the tissue connecting the left and right halves of the brain (corpus callosum) or the hippocampus, which is a region of the brain that is involved in learning and memory.
Beschreibung
DLG4-related synaptopathy is a condition that affects neurological development. This condition is characterised by delayed development and mild to moderate intellectual disabilities that typically becomes evident before age 2. Over time, many individuals with DLG4-related synaptopathy lose skills that they have learned, such as speech or motor skills. About 20 percent of people with this condition cannot speak. Affected individuals often have neurodevelopmental disorders, such as autism spectrum disorder or attention-deficit/hyperactivity disorder. About half of individuals with this condition have recurrent seizures (epilepsy) that typically begin in childhood. Brain changes can also occur. These include brain tissue loss (atrophy) and abnormalities of the tissue connecting the left and right halves of the brain (corpus callosum) or the hippocampus, which is a region of the brain that is involved in learning and memory.
Individuals with DLG4-related synaptopathy can also have weak muscle tone (hyptonia), loose joints (joint laxity), or a spine that curves to the side (scoliosis). Movement problems, including impaired muscle coordination (ataxia), involuntary muscle coordination (dystonia), or rhythmic shaking (tremor) are common in people with this condition. Other problems can include migraine, sleep problems, or anxiety. Some people with DLG4-related synaptopathy have a distinctive body type that includes a long face, slim body, and long fingers.
Less commonly, DLG4-related synaptopathy can affect a person's vision. Affected individuals can have eyes that do not point in the same direction (strabismus), farsightedness (hyperopia), or involuntary movements of the eyes (nystagmus). Some affected individuals have blindness because the area of the brain responsible for processing vision is impaired.
DLG4-related synaptopathy can also cause gastrointestinal difficulties that make it difficult to eat. These can include a backflow of stomach acids into the esophagus (gastroesophageal reflux disease or GERD).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant+New variant. More than one pattern can apply in different cases.
Related genes
Other names
Intellectual developmental disorder 62
intellectual developmental disorder, autosomal dominant 62
SHINE syndrome
sleep disturbances, hypotonia, intellectual disability, neurologic disorder, and epilepsy syndrome
Related patient information and medicines

Patient information leaflet
Polymyalgia rheumatica
This is not a routine test for PMR but may be u... What is the Behandlung für polymyalgia rheumatica. Steroids A steroid medicine Oral steroids such as prednisolone Prednisolone is the usual treatment. Are there any complications with polymyalgia rheumatica. Between 1 and 2 in every 10 people with PMR also develop a related condition called giant.

Patient information leaflet
Kostochondritis
Kostochondritis is a painful chest wall condition, caused by localised inflammation in the joints of the rib cage.

Patient information leaflet
Dengue
How common is it in the UK? 300-400 cases of dengue occur each year in the UK, in travellers returning from countries where dengue is common. It is likely that other mild cases may go undetected. How does a dengue e... Your doctor will want to talk about where you have been, what exposure you have had to biting insects, what vaccinations you have.

Patient information leaflet
Kann ich Lansoprazol und Quetiapin zusammen einnehmen?
Taking lansoprazole and quetiapine together may increase the risk of a rare but serious heart rhythm problem. It can also potentially change how much quetiapine is absorbed into your body. Why this happens Lansoprazole Lansoprazole to reduce stomach acid reduces stomach acid, which can change how quetiapine Quetiapine dissolves and is absorbed. By.

Patient information leaflet
Ohrenschmerzen
Dr Sarah Jarvis MBE The following may help people who devel... For more information, go to [/health/health-advice-for-travel-abroad/ears-and-flying](https://patient.info/health/health-advice-for-travel-abroad/ears-and-flying) Boils, spots and pimples Boils, spots and pimples can occur on the ear just like anywhere else on your.

Patient information leaflet
Kann ich Kollagen und Tamoxifen zusammen einnehmen?
There is no known direct interaction between collagen supplements and tamoxifen. Collagen is a protein found naturally in the body, and taking it as a supplement is generally considered safe alongside this medication. Why this happens Collagen is broken down into amino acids in the digestive tract, similar to eating protein-rich food. It does not.
Weiterführende Lektüre und Referenzen
- DLG4-related synaptopathy; MedlinePlus, National Library of Medicine.
- Levy AM, Gomez-Puertas P, Tumer Z. Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners. Int J Mol Sci. 2022 Apr 15;23(8):4390. doi: 10.3390/ijms23084390.
- Rodriguez-Palmero A, Boerrigter MM, Gomez-Andres D, Aldinger KA, Marcos-Alcalde I, Popp B, Everman DB, Lovgren AK, Arpin S, Bahrambeigi V, Beunders G, Bisgaard AM, Bjerregaard VA, Bruel AL, Challman TD, Cogne B, Coubes C, de Man SA, Denomme-Pichon AS, Dye TJ, Elmslie F, Feuk L, Garcia-Minaur S, Gertler T, Giorgio E, Gruchy N, Haack TB, Haldeman-Englert CR, Haukanes BI, Hoyer J, Hurst ACE, Isidor B, Soller MJ, Kushary S, Kvarnung M, Landau YE, Leppig KA, Lindstrand A, Kleinendorst L, MacKenzie A, Mandrile G, Mendelsohn BA, Moghadasi S, Morton JE, Moutton S, Muller AJ, O'Leary M, Pacio-Miguez M, Palomares-Bralo M, Parikh S, Pfundt R, Pode-Shakked B, Rauch A, Repnikova E, Revah-Politi A, Ross MJ, Ruivenkamp CAL, Sarrazin E, Savatt JM, Schluter A, Schonewolf-Greulich B, Shad Z, Shaw-Smith C, Shieh JT, Shohat M, Spranger S, Thiese H, Mau-Them FT, van Bon B, van de Burgt I, van de Laar IMBH, van Drie E, van Haelst MM, van Ravenswaaij-Arts CM, Verdura E, Vitobello A, Waldmuller S, Whiting S, Zweier C, Prada CE, de Vries BBA, Dobyns WB, Reiter SF, Gomez-Puertas P, Pujol A, Tumer Z. DLG4-related synaptopathy: a new rare brain disorder. Genet Med. 2021 May;23(5):888-899. doi: 10.1038/s41436-020-01075-9. Epub 2021 Feb 17.
- Tumer Z, Dye TJ, Prada C, White-Brown AM, MacKenzie A, Levy AM. DLG4-Related Synaptopathy. 2023 Jun 22. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK592682/
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
3 Nov 2023 | Neueste Version
1. Nov. 2023 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

